Clinical trials
Terminated Phase 2 Staphylococcal Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arsanis, Inc. | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| DermBiont, Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Pfizer | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Staphylococcal Infections | 6 |
| Bacteremia | 1 |
| Dermatitis, Atopic | 1 |
| Endocarditis | 1 |
| Endocarditis, Bacterial | 1 |
| Gram-Positive Bacterial Infections | 1 |
| HIV Infections | 1 |
| Job Syndrome | 1 |
| Pneumonia | 1 |
| Pneumonia, Staphylococcal | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.